Permanently Discontinued

MYLAN-BUPRENORPHINE/NALOXONE

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MYLAN-BUPRENORPHINE/NALOXONE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MYLAN-BUPRENORPHINE/NALOXONE has been permanently discontinued (last updated September 18, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MYLAN-BUPRENORPHINE/NALOXONE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Last updated2019-09-18

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02408090

Tier

Unrated

Last Updated

2019-09-18

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from MYLAN PHARMACEUTICALS ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION, USP

500MG · DIN 02385473

333MG · DIN 02293269

40MG · DIN 02257963

10MG · DIN 02257955

DIN 02388138

DIN 02388146